Artificial intelligence (AI) is revolutionizing head and neck cancer (HNC) care by providing
innovative tools that enhance diagnostic accuracy and personalize treatment strategies. This …

Introduction Artificial intelligence (AI) is exhibiting tremendous potential to reduce the
massive costs and long timescales of drug discovery. There are however important …

Abstract Chronic Kidney Disease (CKD) and its subset Diabetic Kidney Disease (DKD) are
progressive conditions that affect more than 850 million people worldwide. Diabetes …

Genomic medicine has transformed the lives of patients with cancer by enabling
individualised and evidence‐based clinical decision‐making. Despite this progress, the …

Breast cancer patients are categorized into three subtypes with distinct treatment
approaches. Precision oncology has increased patient outcomes by targeting the specific …

Leukemia, although most likely starts as a monoclonal genetic/epigenetic anomaly, is a
polyclonal disease at manifestation. This polyclonal nature results from ongoing …

Objective The presence of artificial intelligence (AI) in healthcare is a powerful and game-
changing force that is completely transforming the industry as a whole. Using sophisticated …

In this study, we explore the possibility of inferring characteristics of the tumor immune
microenvironment from the blood. Specifically, we investigate two datasets of patients with …

Artificial Intelligence (AI) has demonstrated exceptional performance in automating critical
healthcare tasks, such as diagnostic imaging analysis and predictive modeling, often …

While the concept of artificial intelligence (AI) has deep historical roots, its development as a
formal scientific field was initiated in the 1950s by Newell and Simon, who invented a …